NASDAQ · TCBIOFinancialsBanking & Credit

Texas Capital Bancshares, Inc. Depositary Shares 5.75% Fixed Rate Non-Cumulative Perpetual Preferred Stock Series B financials

$18.35−1.56%
Close Sep 28, 2026 · split-adjusted

Revenue

Net income

Income statement & cash flow

Fiscal yearFY25
Dec 31
FY24
Dec 31
FY23
Dec 31
FY22
Dec 31
FY21
Dec 31
Revenue$2.00B$1.76B$1.79B$1.49B$1.01B
Gross profit$1.26B$932.3M$1.08B$1.23B$907.1M
Gross margin62.8%53.0%60.0%82.0%89.4%
Operating income$432.7M$107.1M$246.6M$431.8M$338.1M
Net income$313.0M$60.3M$171.9M$315.2M$235.2M
Net margin15.7%3.4%9.6%21.1%23.2%
Diluted EPS$6.79$1.28$3.54$6.18$4.60
EBITDA$432.7M$107.1M$246.6M$431.8M$338.1M
Operating cash flow$360.2M$480.1M$373.7M$148.0M$773.2M
Free cash flow$347.6M$415.2M$357.4M$136.7M$769.1M
Diluted shares46.1M47.0M48.6M51.0M51.1M

Balance sheet

Period endDec 31Dec 31Dec 31Dec 31Dec 31
Cash & equivalents$201.3M$176.5M$200.5M$233.6M$180.7M
Short-term investments$6.62B$7.41B$7.19B$8.36B$11.35B
Total debt$950.6M$1.55B$2.36B$2.13B$3.13B
Total assets$31.54B$30.73B$28.36B$28.41B$34.73B
Total liabilities$27.91B$27.36B$25.16B$25.36B$31.52B
Shareholders' equity$3.63B$3.37B$3.20B$3.06B$3.21B

From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology